Association of tyrosine protein kinase Zap-70 with the protooncogene product p120(c-cbl) in T lymphocytes

被引:124
|
作者
Fournel, M
Davidson, D
Weil, R
Veillette, A
机构
[1] MCGILL UNIV,MCGILL CANC CTR,MONTREAL,PQ H3G 1Y6,CANADA
[2] MCGILL UNIV,DEPT MED,MONTREAL,PQ H3G 1Y6,CANADA
[3] MCGILL UNIV,DEPT BIOCHEM,MONTREAL,PQ H3G 1Y6,CANADA
[4] MCGILL UNIV,DEPT ONCOL,MONTREAL,PQ H3G 1Y6,CANADA
[5] MONTREAL GEN HOSP,DEPT MED,MONTREAL,PQ H3G 1A4,CANADA
[6] MONTREAL GEN HOSP,DEPT ONCOL,MONTREAL,PQ H3G 1A4,CANADA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 183卷 / 01期
关键词
D O I
10.1084/jem.183.1.301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Accumulating data show that the tyrosine protein kinase Zap-70 plays an essential role in T cell receptor-mediated signal transduction. However, the mode of action, as well as the physiologically relevant substrates of Zap-70, have not been determined. We have attempted to identify a 120-kD tyrosine-phosphorylated protein (p120) that associates with Zap-70 in activated T lymphocytes. The results of our analyses showed that p120 is largely encoded by the c-cbl protooncogene. Furthermore, the association of Zap-70 with c-Cbl was shown to be induced by T cell receptor stimulation, implying that it required posttranslational modification of one or both of these products. FynT, but not Lck, also associated with c-Cbl in activated T cells. Finally, using a heterologous system, it was demonstrated that the ability of Zap-70 to cause ryrosine phosphorylation of p120(c-cbl) was dependent on Lck- or FynT-mediated signals. As c-Cbl can associate with several other signaling molecules, it may couple Zap-70 to downstream effectors during T cell activation.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 50 条
  • [1] The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation
    Lin, HM
    Martelli, MP
    Bierer, BE
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (01) : 13 - 22
  • [2] p210(BCR/ABL) induces formation of complexes containing focal adhesion proteins and the protooncogene product p120(c-Cbl)
    Salgia, R
    Sattler, M
    Pisick, E
    Li, JL
    Griffin, JD
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (02) : 310 - 313
  • [3] Identification and characterization of a substrate specific for the T cell protein tyrosine kinase ZAP-70
    Watts, JD
    Brabb, T
    Bures, EJ
    Wange, RL
    Samelson, LE
    Aebersold, R
    FEBS LETTERS, 1996, 398 (2-3): : 217 - 222
  • [4] Down-modulation of the ZAP-70 protein tyrosine kinase in macaque T lymphocytes infected with SIVsmmPBj14
    Thai, TH
    Fultz, PN
    JOURNAL OF MEDICAL PRIMATOLOGY, 1998, 27 (2-3) : 141 - 147
  • [5] RECONSTITUTION OF SYK FUNCTION BY THE ZAP-70 PROTEIN-TYROSINE KINASE
    KONG, GH
    BU, JY
    KUROSAKI, T
    SHAW, AS
    CHAN, AC
    IMMUNITY, 1995, 2 (05) : 485 - 492
  • [6] THE PROTEIN PRODUCT OF THE C-CBL PROTOONCOGENE IS THE 120-KDA TYROSINE-PHOSPHORYLATED PROTEIN IN JURKAT CELLS ACTIVATED VIA THE T-CELL ANTIGEN RECEPTOR
    DONOVAN, JA
    WANGE, RL
    LANGDON, WY
    SAMELSON, LE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (37) : 22921 - 22924
  • [7] Structure of the human ZAP-70 protein tyrosine kinase gene.
    Elder, ME
    Wang, FL
    Lin, D
    PEDIATRIC RESEARCH, 1996, 39 (04) : 45 - 45
  • [8] Specific association of tyrosine-phosphorylated c-Cbl with Fyn tyrosine kinase in T cells
    Tsygankov, AY
    Mahajan, S
    Fincke, JE
    Bolen, JB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) : 27130 - 27137
  • [9] Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor
    Marcos H. Hatada
    Xiaode Lu
    Ellen R. Laird
    Jeremy Green
    Jay P. Morgenstern
    Meizhen Lou
    Chris S. Marr
    Thomas B. Phillips
    Mary K. Ram
    Kelly Theriault
    Mark J. Zoller
    Jennifer L. Karas
    Nature, 2007, 446 : 824 - 824
  • [10] A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase
    Thien, CBF
    Scaife, RM
    Papadimitriou, JM
    Murphy, MA
    Bowtell, DDL
    Langdon, WY
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04): : 503 - 513